Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (121-130 of 353) with videos related to

Pageof 36
Sort By:
The American Journal of Cardiology|July 16, 2003
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromesDeepak L Bhatt, Derek P Chew, A Michael Lincoff, et al.
The American Journal of Cardiology|February 5, 2004
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingAndreas Koster, Bruce Spiess, Derek P Chew, et al.
The American Journal of Cardiology|October 24, 2007
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 TrialFrederick Feit, Michele D Voeltz, Michael J Attubato, et al.
Advances in Therapy|March 29, 2025
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without DiabetesChristopher Lübker, Jigish Bhavsar, Ruben Duque do Vale, et al.
JACC. Heart Failure|October 16, 2025
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection FractionBarry A Borlaug, Cecilie Holse, Mette Holme Jung, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The Annals of Thoracic Surgery|January 30, 2007
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trialAndreas Koster, Cornelius M Dyke, Gabriel Aldea, et al.
The American Journal of Cardiology|October 15, 2003
Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trialsDerek P Chew, Deepak L Bhatt, William Kimball, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
Journal of the American Heart Association|August 2, 2021
Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial InfarctionRaunak Nair, Michael Johnson, Kathleen Kravitz, et al.
Pageof 36

Showing results (121-130 of 353) with videos related to

Sort By:
Pageof 36
The American Journal of Cardiology|July 16, 2003
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromesDeepak L Bhatt, Derek P Chew, A Michael Lincoff, et al.
The American Journal of Cardiology|February 5, 2004
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingAndreas Koster, Bruce Spiess, Derek P Chew, et al.
The American Journal of Cardiology|October 24, 2007
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 TrialFrederick Feit, Michele D Voeltz, Michael J Attubato, et al.
Advances in Therapy|March 29, 2025
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without DiabetesChristopher Lübker, Jigish Bhavsar, Ruben Duque do Vale, et al.
JACC. Heart Failure|October 16, 2025
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection FractionBarry A Borlaug, Cecilie Holse, Mette Holme Jung, et al.
The American Journal of Cardiology|September 26, 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomesJuhana Karha, Hitinder S Gurm, Vivek Rajagopal, et al.
The Annals of Thoracic Surgery|January 30, 2007
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trialAndreas Koster, Cornelius M Dyke, Gabriel Aldea, et al.
The American Journal of Cardiology|October 15, 2003
Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trialsDerek P Chew, Deepak L Bhatt, William Kimball, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
Journal of the American Heart Association|August 2, 2021
Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial InfarctionRaunak Nair, Michael Johnson, Kathleen Kravitz, et al.
Pageof 36